The second (and third) wave of the pandemic continues as the end-of-year holiday season approaches. Here are strategies to fight Zoom fatigue while staying virtually close to your loved ones.
Academic rigour, journalistic flair
Articles on COVID-19
Displaying 3881 - 3900 of 7973 articles
Calls for help to domestic violence shelters have risen during the pandemic, as risk factors for the escalation of violence have gone up. It may be time to implement new strategies to help.
With new US COVID-19 cases topping 200,000 a day, contact tracers are overwhelmed. Here’s how infected people can start tracing and notifying contacts themselves.
A pharmaceutical supply chain expert explains the challenges of distributing the COVID-19 vaccines from Pfizer and Moderna that need to be kept at very low temperatures.
Other faiths have managed to give up their celebrations and pilgrimages. Surely we can put up with a low-key Christmas?
Initial studies suggest these drugs, widely taken to lower cholesterol, may also reduce the severity of COVID-19.
Indonesia is paying the price for failing to control the spread of the coronavirus. The country needs to change course and give priority to public health as the first step in repairing the economy.
After more than a month of testing without a single positive case, the probability of coronavirus lurking in Victoria is vanishingly small.
With a vaccine now approved in the UK, other countries won’t be far behind. But a vaccine won’t singlehandedly ensure the virus doesn’t cross international borders when travel picks up.
Medicine’s linguistic history in English is rich indeed, peppered with borrowings from French. But the Old English renderings retain a certain charm.
A new study has shown that there are sex-based differences in how we respond to the coronavirus.
Governments can align their policies to tackle both climate change and post-pandemic recovery.
Zoom shares tumbled with the announcement of a vaccine - but reactive markets don’t reflect people’s desire to keep working from home
It turns out, if your crisps are sufficiently ‘niche’ and sophisticated, even they can be classed as a meal.
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.
Combating social media disinformation regarding vaccines is critical to reversing the growth in vaccine hesitancy around the world.
‘Sensible’ public figures have far less influence on our behaviour than it seems
Women felt more worn out by restrictions – while men complained of boredom
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
Top contributors
-
Professorial Fellow, University of Canberra
-
Associate Professor, Epidemiology, Deakin University
-
Professor of Economics, UNSW Sydney
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Chair in Epidemiology, Deakin University
-
Professor of Biostatistics and Epidemiology, University of South Australia
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Visiting Fellow, Crawford School of Public Policy, Australian National University
-
Senior Research Fellow in Global Health, University of Southampton
-
Professor of Medicine, University of East Anglia
-
Associate Professor, School of Population Health, UNSW Sydney
-
Professor of Medicine, University of Virginia
-
Professor of Public Health, University of Sheffield
-
Associate Professor of Bioethics, University of Portsmouth
